107 related articles for article (PubMed ID: 7683842)
1. Interferon alfa-2a in the treatment of subfoveal choroidal neovascularization.
Thomas MA; Ibanez HE
Am J Ophthalmol; 1993 May; 115(5):563-8. PubMed ID: 7683842
[TBL] [Abstract][Full Text] [Related]
2. Interferon alfa-2a modifies the course of subfoveal and juxtafoveal choroidal neovascularisation.
Engler C; Sander B; Villumsen J; Lund-Andersen H
Br J Ophthalmol; 1994 Oct; 78(10):749-53. PubMed ID: 7528534
[TBL] [Abstract][Full Text] [Related]
3. Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Pharmacological Therapy for Macular Degeneration Study Group.
Arch Ophthalmol; 1997 Jul; 115(7):865-72. PubMed ID: 9230826
[TBL] [Abstract][Full Text] [Related]
4. Interferon alpha-2a in the treatment of exudative senile macular degeneration.
Jaakkola A; Anttila PM; Immonen I
Acta Ophthalmol (Copenh); 1994 Oct; 72(5):545-9. PubMed ID: 7534027
[TBL] [Abstract][Full Text] [Related]
5. Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration.
Poliner LS; Tornambe PE; Michelson PE; Heitzmann JG
Ophthalmology; 1993 Sep; 100(9):1417-24. PubMed ID: 8371932
[TBL] [Abstract][Full Text] [Related]
6. Treatment of choroidal neovascularization in age-related macular degeneration with interferon alpha-2a: a short term, nonrandomized pilot study.
Thoelen A; Menozzi M; Huber C; Messmer E
Ger J Ophthalmol; 1995 May; 4(3):137-43. PubMed ID: 7545047
[TBL] [Abstract][Full Text] [Related]
7. Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b.
Gillies MC; Sarks JP; Beaumont PE; Hunyor AB; McKay D; Kearns M; McClusky PJ; Sarks SH
Br J Ophthalmol; 1993 Dec; 77(12):759-65. PubMed ID: 7509184
[TBL] [Abstract][Full Text] [Related]
8. Treatment of subfoveal choroidal neovascular membranes with systemic interferon-alpha 2a.
Loughnan MS; Heriot WJ; O'Day J
Aust N Z J Ophthalmol; 1992 Aug; 20(3):173-5. PubMed ID: 1280447
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.
Kirkpatrick JN; Dick AD; Forrester JV
Br J Ophthalmol; 1993 Dec; 77(12):766-70. PubMed ID: 7509185
[TBL] [Abstract][Full Text] [Related]
10. Interferon for subfoveal choroidal neovascularisation.
Groeneveld E; Eliadis P
Aust N Z J Ophthalmol; 1993 May; 21(2):133-4. PubMed ID: 7687445
[No Abstract] [Full Text] [Related]
11. The treatment of choroidal neovascular membranes by alpha interferon. An efficacy and toxicity study.
Chan CK; Kempin SJ; Noble SK; Palmer GA
Ophthalmology; 1994 Feb; 101(2):289-300. PubMed ID: 7509472
[TBL] [Abstract][Full Text] [Related]
12. Interferon alpha-2a treatment of patients with subfoveal neovascular macular degeneration. A pilot investigation.
Engler CB; Sander B; Koefoed P; Larsen M; Vinding T; Lund-Andersen H
Acta Ophthalmol (Copenh); 1993 Feb; 71(1):27-31. PubMed ID: 7682747
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal interferon alpha-2b for the treatment of neovascular age-related macular degeneration: a pilot study.
Kertes PJ; Britton WA; Leonard BC
Can J Ophthalmol; 1997 Apr; 32(3):185-8. PubMed ID: 9131284
[No Abstract] [Full Text] [Related]
14. Translocation of the retina for management of subfoveal choroidal neovascularization II: a preliminary report in humans.
de Juan E; Loewenstein A; Bressler NM; Alexander J
Am J Ophthalmol; 1998 May; 125(5):635-46. PubMed ID: 9625547
[TBL] [Abstract][Full Text] [Related]
15. Surgical removal of subfoveal neovascularization in idiopathic juxtafoveolar retinal telangiectasis.
Berger AS; McCuen BW; Brown GC; Brownlow RL
Retina; 1997; 17(2):94-8. PubMed ID: 9143035
[TBL] [Abstract][Full Text] [Related]
16. The natural history of idiopathic subfoveal choroidal neovascularization.
Ho AC; Yannuzzi LA; Pisicano K; DeRosa J
Ophthalmology; 1995 May; 102(5):782-9. PubMed ID: 7539905
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy for age-related subfoveal choroidal neovascular membranes. A pilot study.
Bergink GJ; Deutman AF; van den Broek JE; van Daal WA; van der Maazen RM
Doc Ophthalmol; 1995; 90(1):67-74. PubMed ID: 8549245
[TBL] [Abstract][Full Text] [Related]
18. Visual results after submacular surgery for neovascularization in age-related macular degeneration.
Roth DB; Downie AA; Charles ST
Ophthalmic Surg Lasers; 1997 Nov; 28(11):920-5. PubMed ID: 9387179
[TBL] [Abstract][Full Text] [Related]
19. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
Verteporfin In Photodynamic Therapy Study Group
Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
[TBL] [Abstract][Full Text] [Related]
20. Follow-up study in eyes with choroidal neovascularization caused by presumed ocular histoplasmosis.
Klein ML; Fine SL; Knox DL; Patz A
Am J Ophthalmol; 1977 Jun; 83(6):830-5. PubMed ID: 868984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]